RedHill Biopharma's (RDHL) Movantik Added To Medicare Part D Formulary

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. LRCX
7. LVS
8. CSX
9. QGEN
10. KNX

Go back to RedHill Biopharma's (RDHL) Movantik Added To Medicare Part D Formulary

Redhill Biopharma (RDHL) PT Lowered to $10 at BTIG

December 1, 2021 6:00 AM EST

BTIG analyst Robert Hazlett lowered the price target on Redhill Biopharma (NASDAQ: RDHL) to $10.00 (from $16.00) while maintaining a Buy rating.... More

RedHill Biopharma (RDHL) Tops Q3 EPS by 16c

November 30, 2021 7:05 AM EST

RedHill Biopharma (NASDAQ: RDHL) reported Q3 EPS of ($0.05), $0.16 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $21.6 million versus the consensus estimate of $24.52 million.

For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.

... More